Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
3D Printing of Pharmaceuticals and Drug Delivery Devices
| 3D Printing of Pharmaceuticals and Drug Delivery Devices |
| Autore | Lamprou Dimitrios A |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 electronic resource (436 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
digital pharmacy
fused deposition modeling 3D printing modified drug release personalized medicines telemedicine three dimensional printing additive manufacturing 3D printed drug products printlets personalised medicines personalized pharmaceuticals multiple units spheroids beads acetaminophen 3D printing fused filament fabrication lignin antioxidant materials wound dressing modified release filament extrusion fused layer modeling theophylline high API load three-dimensional printing fixed-dose combinations tablets multiple-layer dosage forms stereolithography vat polymerisation fused deposition modeling polylactic acid chemical modification MTT assay biofilm formation warfarin semisolid extrusion 3D printing inkjet printing orodispersible film oral powder pediatric hospital pharmacy personalized medicine on-demand manufacturing drug delivery micromedicine drug development micro-swimmer micro-implant oral dosages microneedle high-precision targeting controlled release geometry resolution feature size release profile vascularization digital light processing technology neural networks optimization prediction FMD pregabalin gastric floating complex structures patient-specific structural design gums Fused Deposition Modeling 3D Printing processing parameters pharmaceutical quality control hot-melt extrusion solid dosage forms 3D printed oral dosage forms sustained drug release tablets photopolymerization paracetamol (acetaminophen) aspirin (acetylsalicylic acid) amorphous solid dispersion poor solubility fixed dose combination stencil printing pharmacoprinting orodispersible discs orodisperible films floating systems pulsatile release chronotherapeutic delivery wound-healing 3D bio-printing pectin propolis cyclodextrin 3D bio-inks fused deposition modelling extrusion vaginal meshes mechanical properties drug release anti-infective devices pelvic organ prolapse stress urinary incontinence gastro-retentive floating system dissolution kinetics implantable devices subcutaneous biodegradable prolonged drug delivery polymers pharmaceuticals extrusion-based 3D printing fused deposition modeling (FDM) pressure-assisted microsyringe (PAM) materials process 3D bioprinting polymeric ink pseudo-bone implantable scaffold computer-aided design (CAD) design bioprinting computer-aided design (CAD) pharmaceutics |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557780703321 |
Lamprou Dimitrios A
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside
| Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside |
| Autore | Tagit Oya |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 electronic resource (296 p.) |
| Soggetto topico |
Technology: general issues
History of engineering & technology Materials science |
| Soggetto non controllato |
poly(lactic-co-glycolic acid) (PLGA)
blood–brain barrier (BBB) current Good Manufacturing Practice (cGMP) Food and Drug Administration (FDA) nanotechnology PLGA nanoparticles neurodegenerative diseases drug delivery central nervous system neuroprotective drugs fluorescent labeling DiI coumarin 6 rhodamine 123 Cy5.5 quantum yield brightness stability of fluorescent label confocal microscopy intracellular internalization in vivo neuroimaging double-emulsion method dry powder inhalation antigen release porous PLGA particles microfluidics methotrexate chitosan PLA/PLGA sustained release micro-implant animal model minimally invasive drug delivery system nanoparticles poly (lactic-co-glycolic acid) (PLGA) microfluidic pharmacokinetics (PK) and biodistribution atorvastatin calcium poly(lactide-co-glycolide) polymeric nanoparticles carrageenan induced inflammation anti-inflammatory radiolabeled nanoparticles nuclear medicine photothermal therapy phthalocyanine SKOVip-kat Katushka TurboFP635 JO-4 PLGA orthotopic tumors 3D culture spheroids poly(lactic-co-glycolic acid) nanomedicine scale-up manufacturing clinical translation inline sonication tangential flow filtration lyophilization downstream processing H. pylori design of experiments poly(lactic-co-glycolic) acid size cancer chemoimmunotherapy immunogenic cell death immune checkpoint blockade PNA5 glycopeptide mas receptor angiotensin PLGA diblock copolymer ester and acid-end capped double emulsion solvent evaporation biocompatible biodegradable cardiovascular nanoparticle solid-state characterization in vitro drug release kinetics modeling PEGylation amine emulsion polyvinyl alcohol (PVA) Pluronic triblock copolymer trehalose sucrose Indomethacin solvents stabilizers morphology particle-size encapsulation drug release cytotoxicity |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease |
| Record Nr. | UNINA-9910580215803321 |
|
Tagit Oya
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||